SCHEMBL9944856

SCHEMBL9944856

CCNC(=O)c1cc([N+](=O)[O-])c(NC)cc1N(C)c1ccc(F)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
EGFR P00533 1/20 0.38
ALDH1A1 P00352 7/20 0.37
MAPT P10636 6/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 2/20 0.37
GAA P10253 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
HPGD P15428 4/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HCAR3 P49019 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944850 0.84 PTGES (0.39) PTGESNPC1RAB9AEGFRALDH1A1
SCHEMBL9944848 0.82 MEN1 (0.42) PTGESNPC1RAB9AEGFRALDH1A1
SCHEMBL9944732 0.77 EGFR (0.51) NPC1RAB9AEGFRALDH1A1MAPT
SCHEMBL9944752 0.77 HCAR3 (0.43) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL9946619 0.76 PTGES (0.49) PTGESEGFRALDH1A1KMT2A
SCHEMBL9944852 0.75 HCAR3 (0.46) ALDH1A1MAPTSMN1; SMN2HTTL3MBTL1
SCHEMBL9944838 0.74 ALDH1A1 (0.39) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL9898699 0.73 EGFR (0.47) PTGESEGFRALDH1A1MAPTSMN1; SMN2
SCHEMBL9944844 0.72 ALDH1A1 (0.45) NPC1RAB9AALDH1A1MAPTHTT
SCHEMBL9944834 0.72 EGFR (0.49) NPC1RAB9AEGFRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES PTGES 3/4885NPC1 1695/4885RAB9A 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.